Clinical Trials
3 trialsNCT02265536 2024-10-28
A Study of LY3022855 In Participants With Breast or Prostate Cancer
Eli Lilly and Company
Phase 1 Completed
NCT01346358 2024-09-19
A Study of IMC-CS4 in Subjects With Advanced Solid Tumors
Eli Lilly and Company
Phase 1 Completed
NCT02718911 2023-10-16
A Study of LY3022855 in Combination With Durvalumab or Tremelimumab in Participants With Advanced Solid Tumors
Eli Lilly and Company
Phase 1 Completed